SIT INVESTMENT ASSOCIATES INC - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 159 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.

Quarter-by-quarter ownership
SIT INVESTMENT ASSOCIATES INC ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q4 2018$1,048,000
-4.7%
78,4500.0%0.03%
+21.4%
Q3 2018$1,100,000
-26.9%
78,450
-18.0%
0.03%
-28.2%
Q2 2018$1,504,000
-4.4%
95,6500.0%0.04%0.0%
Q1 2018$1,573,000
-8.9%
95,6500.0%0.04%
-4.9%
Q4 2017$1,727,000
+48.1%
95,650
+58.4%
0.04%
+41.4%
Q3 2017$1,166,000
+57.8%
60,400
-3.5%
0.03%
+61.1%
Q2 2017$739,00062,6000.02%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Consonance Capital Management LP 5,188,417$85,349,0007.80%
TANAKA CAPITAL MANAGEMENT INC 144,602$2,379,0005.69%
INGALLS & SNYDER LLC 6,817,540$112,149,0005.47%
NEXTHERA CAPITAL LP 1,045,196$17,193,0002.83%
Timpani Capital Management LLC 245,279$4,035,0001.41%
S&T BANK/PA 426,257$7,012,0001.25%
SHAKER INVESTMENTS LLC/OH 107,670$1,771,0001.10%
ESSEX INVESTMENT MANAGEMENT CO LLC 434,624$7,150,0000.94%
AMI ASSET MANAGEMENT CORP 709,300$11,668,0000.83%
Birchview Capital, LP 75,500$1,242,0000.82%
View complete list of CORCEPT THERAPEUTICS INC shareholders